Data coverage, completeness and provenance for Bio-Techne in the Stock Market API — Health Care · Biotechnology.
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.
Employees: 3,000 · Website: https://www.bio-techne.com · Profile fields populated: 75%
Share of stored fields populated in the anchor reporting period (FY2026), primary source sec_edgar. Full per-field breakdown: GET /api/v1/companies/TECH/financials.
Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.
| Period | Period end | Revenue | Net income | Total assets | Total equity | Fields populated | Source |
|---|---|---|---|---|---|---|---|
| FY2026 | 2026-06-30 | 29 | sec_edgar | ||||
| FY2025 | 2025-06-30 | 29 | sec_edgar | ||||
| FY2024 | 2024-06-30 | 29 | sec_edgar | ||||
| FY2023 | 2023-06-30 | 29 | sec_edgar | ||||
| FY2022 | 2022-06-30 | 29 | sec_edgar |
Every number on this page is one API call away. Free API keys — no card required.
Name, sector, industry, HQ, employees, market cap, source-tagged.
GET /api/v1/companies/TECH
Multi-year statements with per-field source tags and completeness.
GET /api/v1/companies/TECH/financials
P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.
GET /api/v1/companies/TECH/metrics/summary
Report PDFs with LLM-ready markdown conversions where available.
GET /api/v1/companies/TECH/filings
Dated press releases and announcements with source links.
GET /api/v1/companies/TECH/news
Create a free key, then:
curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/TECH
Free tier — instant API key. Built for AI agents.